glucosylceramide synthase inhibitors (Macrozyme/Genzyme)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameglucosylceramide synthase inhibitors (Macrozyme/Genzyme)
Drug Alias NameGenz-123346glycosphingolipid synthesis inhibitor (Macrozyme)imino sugar derivative (Macrozyme)GZ-667161MZ-021
ClassificationSmall molecules
Mechanisms of ActionCeramide glucosyltransferase inhibitors
TargetsCeramide glucosyltransferase
Therapy Area/IndicationsDiabetes Mellitus, Type 2Parkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Amsterdam
China Registration ClassN/A

Develop Information

Active CompaniesGenzyme Corp
Active IndicationsParkinson Disease
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A